FDA panel backs Amgen?s cholesterol drug for high-risk patients
 

FDA panel backs Amgen?s cholesterol drug for high-risk patients
WASHINGTON (Reuters) - An advisory panel to the U.S. Food and Drug Administration recommended approval of Amgen Inc's cholesterol-lowering drug Repatha but said it should be only used in patients at high risk of cardiovascular disease.http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1


http://da.feedsportal.com/r/23104933...19/rc/1/rc.img
http://da.feedsportal.com/r/23104933...19/rc/2/rc.img
http://da.feedsportal.com/r/23104933...19/rc/3/rc.img

http://da.feedsportal.com/r/23104933...0/sc/19/a2.img
http://adchoice.feedsportal.com/r/23.../sc/19/ach.imghttp://pi.feedsportal.com/r/23104933.../sc/19/a2t.imghttp://pi2.feedsportal.com/r/2310493...sc/19/a2t2.imghttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...TA:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...TA:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/m_M7iwYb2ag